ArticlePeerJ2013

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells.

Ricardo Parrondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.